Ethnicity and risks of severe COVID-19 outcomes associated with glucose-lowering medications: a cohort study. (2022)
Attributed to:
Epidemiological contribution to primary and secondary prevention of diabetes and obesity
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.88617
Publication URI: https://www.repository.cam.ac.uk/handle/1810/341192
Type: Journal Article/Review